Status:
COMPLETED
A Phase 1 PK Study of Tolperisone in Healthy Subjects
Lead Sponsor:
Neurana Pharmaceuticals, Inc.
Conditions:
Healthy
Eligibility:
All Genders
18-64 years
Phase:
PHASE1
Brief Summary
This is a randomized, single-blind, single and multiple dose crossover subjects in healthy adult subjects
Detailed Description
This is a single-center, in-patient, treatment sequence-randomized, single-blind SD and MD crossover study in 27 healthy adult male and female subjects. Subjects will be admitted to the clinic on Day-...
Eligibility Criteria
Inclusion
- Generally Healthy Subjects
- BMI between 18.5 and 32.5 kg/m2
Exclusion
- \- pregnant or breastfeeding
Key Trial Info
Start Date :
July 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04465266
Start Date
July 28 2020
End Date
September 1 2021
Last Update
February 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Worldwide Clinical Trials Early Phase Services, LLC
San Antonio, Texas, United States, 78217